<< see all grants
Programme for:institutions
What can be funded:

Research and Development Works

Deadline for submitting the proposals:02/01/2022 - 16/02/2022
Published by:Narodowe Centrum Badań i Rozwoju NCBR

National Center for Research and Development

Keywords:NCBR, Rare Diseases, UE FUNDS
Contact:National Institute of Health Carlos III (ISCIII), Joint Call Secretariat
Ignacio Baanante, Maria Druet
E-mail: ibaanante@isciii.es
E-mail: mdruet@isciii.es

Marcin Chmielewski
Tel. 48 22 39 07 109
Tel. 48 571 226 666
E-mail: marcin.chmielewski@ncbr.gov.pl

The European Joint Programme on Rare Diseases (EJP RD) is a programme aiming to create an effective rare diseases research ecosystem for progress, innovation and for the benefit of everyone with a rare disease. We support rare diseases stakeholders by funding research, bringing together data resources & tools, providing dedicated training courses, and translating high quality research into effective treatments.

More information:https://www.gov.pl/web/ncbr/ejp-rd-iv-konkurs-2022



More information: https://www.ejprarediseases.org/

The European Joint Programme on Rare Diseases (EJP RD) brings over 130 institutions (including all 24 ERNs)  from 35 countries:

  • 26 EU Member States (Austria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Croatia, Ireland, Italy, Netherlands, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Spain, Sweden, Slovakia, Slovenia)
  • 7 associated (Armenia, Georgia, Israel, Norway, Serbia, Switzerland, Turkey)
  • Uk & Canada

to create a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation.

As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profit from coordination on a European and international scale. RD research should be improved to overcome fragmentation, leading to efficacious use of data and resources, faster scientific progress and competitiveness, and most importantly to decrease unnecessary hardship and prolonged suffering of RD patients.

In the specific context of the massive generation, need for reuse and efficient interpretation of data, introduction of omics into care practice and the structuration of RD care centers in European Reference Networks, it appears crucial and timely to maximize the potential of already funded tools and programmes by supporting them further, scaling up, linking, and adapting them to the needs of end-users through implementation tests in real settings. To achieve this goal, the EJP RD has two major objectives:

  1. To improve the integration, the efficacy, the production and the social impact of research on RD through the development, demonstration and promotion of Europe/world-wide sharing of research and clinical data, materials, processes, knowledge and know-how
  2. To implement and further develop an efficient model of financial support for all types of research on RD (fundamental, clinical, epidemiological, social, economic, health service) coupled with accelerated exploitation of research results for benefit of patients.

To this end, the EJP RD actions are organized within five major Pillars assisted by the central coordination and transversal activities:

Pillar 0: Coordination, Transversal Activities & Communication

Pillar 1: Fundings and Calls

Pillar 2: Coordinated Access to Data and Services

Pillar 3: Training and Empowerment

Pillar 4: Innovation and Clinical Trials Support 


Research field